Immunology
| 5 min read
After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis.
| 6 min read
Hair loss affects millions, and a new wave of therapies — from drugs to cell-based treatments — could finally offer safe, effective, and lasting solutions.
| 4 min read
Cancer diagnostic technologies, advances on brain map models, pharmaceutical deals, and more led the news this week.
| 9 min read
Industry leaders predict this year will be shaped by AI-driven discovery, human-relevant safety testing, and tighter capital discipline.
| 4 min read
FDA guidance now limits routine tissue biopsies, forcing researchers to rethink how blood biopsies can be optimized to reveal tissue biology.
| 3 min read
Phase 2 trial shows that a topical drug rapidly reduces malodor, pain, and improves quality of life for patients with malignant fungating wounds.
| 2 min read
New GlycoLiner kits enable rapid, covalent labeling of live-cell surface glycoproteins using gentle, self-catalyzing chemistry at neutral pH.
| 5 min read
Pioneering transplants from pigs to humans could mark a turning point for organ replacement.
| 6 min read
A clinical trial showed that Rhapsido can safely and effectively treat chronic spontaneous urticaria; its developer Novartis hopes that’s just the start.
| 2 min read
ProBioGen will apply its CHO.RiGHT platform and GlymaxX technology to support Spica’s first clinical candidate, the anti-CD163 antibody ST101.
| 10+ min read
Bioelectricity is a potent lever for controlling health. What would it look like to treat the body electrically, rather than chemically?
| 6 min read
Harnessing human-first models to accelerate drug discovery, improve safety, and capture the diversity of human biology.
